ChemoCentryx (CCXI) Completes 4.5M IPO
Up)
ChemoCentryx, Inc. (Nasdaq: CCXI) has completed its initial public offering of 4,500,000 shares of common stock. In addition, the underwriters of its initial public offering exercised their over-allotment option in full and purchased an additional 675,000 shares of common stock. All of such shares were sold by ChemoCentryx at an initial public offering price of $10.00 per share. J.P. Morgan and Citigroup acted as joint book-running managers of the offering, and Cowen and Company acted as co-manager of the offering.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Hill International (HIL) Receives $16.1 Million Contract From LA County Metro Transportation Authority
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
Create E-mail Alert Related Categories
Corporate News, IPOsRelated Entities
JPMorgan, Citi, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
